GO:0070202 regulation of establishment of protein localization to chromosome: Chromatin Targeting Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070202 describes the regulatory processes that control how proteins are delivered to specific chromosomal locations, a step essential for gene expression, DNA repair, and chromosome segregation.
• Key molecular players include chromatin-modifying enzymes, histone readers, and nuclear transport factors that recognize histone marks and guide protein cargo to chromatin.
• Disruption of this regulation is linked to acute myeloid leukemia, where mutations in cohesin complex genes such as STAG2 reshape chromatin architecture and alter gene regulation.
• The process is also critical for X-chromosome inactivation, where stepwise establishment of inactive X architecture depends on regulated protein localization.
• Metabolic enzymes such as MTHFD2 can localize to the nucleus and are required for correct mitosis progression, showing that non-canonical chromatin targeting supports cell division.
• Experimental approaches including CRISPR knockout, knock-in of tagged proteins, and proximity-labeling proteomics (e.g., ChromID) are used to dissect these regulatory mechanisms.
Description
The regulation of establishment of protein localization to chromosome (GO:0070202) encompasses any process that modulates the frequency, rate, or extent of the directed movement of a protein to a specific location on a chromosome. This biological process is fundamental to genome function because the correct spatial and temporal deposition of proteins onto chromatin governs transcription, DNA replication, and repair. For researchers, understanding this regulatory layer is critical for interpreting how cells maintain epigenetic states and respond to developmental or oncogenic signals. Proteins are not delivered to chromosomes randomly; their localization is controlled by a combination of chromatin marks, histone modifications, and nuclear transport machinery. For example, promoter-bound METTL3 is recruited to specific genomic loci to maintain m6A-dependent translation control in myeloid leukemia, illustrating how regulated localization directly impacts disease. Similarly, the stepwise de novo establishment of inactive X chromosome architecture requires precise regulation of protein targeting to chromatin during early development. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0070202. We cover the definition, key genes, regulatory mechanisms, disease relevance, and experimental models, with a focus on how CRISPR-based tools can be applied to study this process.
regulation of establishment of protein localization to chromosome At A Glance
| GO ID | GO:0070202 |
|---|---|
| GO term | regulation of establishment of protein localization to chromosome |
| Ontology | biological_process |
| Synonym | regulation of establishment of protein localisation to chromosome |
| Major function | Modulates the directed movement of proteins to specific chromosomal locations, influencing gene expression, DNA repair, and chromosome segregation. |
| Related processes | Chromatin remodeling, histone modification, nuclear transport, and cell cycle progression. |
| Disease relevance | Implicated in acute myeloid leukemia, X-chromosome inactivation disorders, and mitotic defects. |
| Experimental models | CRISPR knockout, knock-in of tagged proteins, overexpression, and proximity-labeling proteomics. |
What Is GO:0070202?
GO:0070202 is defined by QuickGO as any process that modulates the frequency, rate or extent of the directed movement of a protein to a specific location on a chromosome. In other words, it is the regulatory layer that ensures proteins reach the right chromosomal address at the right time, rather than a description of the movement itself. This term sits under the broader biological process of protein localization to chromosome and includes mechanisms such as chromatin mark recognition, histone modification-dependent recruitment, and nuclear transport regulation.
Why Is regulation of establishment of protein localization to chromosome Important in Cell Biology?
Regulation of protein localization to chromosomes is a central node in epigenetic control because it determines which proteins access specific genomic regions. Errors in this process can lead to inappropriate gene activation or silencing, defective DNA repair, and chromosomal instability, all of which contribute to diseases such as cancer and developmental disorders. Understanding GO:0070202 therefore provides mechanistic insight into how cells maintain genome integrity and how perturbations drive pathology.
• Controls access of transcription factors and chromatin modifiers to specific genomic loci, thereby regulating gene expression.
• Ensures proper deposition of histone variants and modifications during DNA replication and repair.
• Required for stepwise establishment of inactive X chromosome architecture in early development.
• Dysregulation is linked to acute myeloid leukemia through mutations in cohesin complex genes such as STAG2.
• Nuclear localization of metabolic enzymes like MTHFD2 is required for correct mitosis progression.
• Provides a mechanistic basis for understanding how oncogenic fusion proteins are targeted to chromatin.
• Offers targets for therapeutic intervention in cancers dependent on chromatin-bound proteins.
• Enables researchers to design CRISPR screens that interrogate chromatin targeting pathways.
• Helps explain how environmental and metabolic cues influence epigenetic states.
• Supports development of biomarkers for diseases characterized by chromatin mislocalization.
What Happens During regulation of establishment of protein localization to chromosome?
Recognition of Chromatin Marks
In simple terms: Proteins find their chromosomal destinations by reading chemical tags on histones.
The first step in regulated protein localization to chromosomes is the recognition of specific chromatin marks, such as methylated or acetylated histone tails. ChromID, a proximity-labeling approach, has been used to identify protein interactomes at specific chromatin marks, revealing that distinct histone modifications recruit unique sets of effector proteins. For example, promoter-bound METTL3 is recruited to chromatin in an m6A-dependent manner to maintain translation control in myeloid leukemia. This recognition step ensures that proteins are delivered only to appropriate genomic regions.
Histone Modification and Acetylation
In simple terms: Enzymes add or remove chemical tags on histones, which can attract or repel specific proteins.
Histone acetylation, regulated by enzymes such as acetyl-CoA synthetase, influences the recruitment of bromodomain-containing proteins to chromatin. In hippocampal memory formation, acetyl-CoA synthetase regulates histone acetylation, demonstrating that metabolic enzymes can control the chromatin-binding landscape. This modification step is a key regulatory node in GO:0070202 because it determines which proteins can establish stable interactions with chromosomes.
Nuclear Transport and Spatial Regulation
In simple terms: Proteins must first enter the nucleus and then find the right chromosome region.
Regulation also occurs at the level of nuclear transport. For instance, nuclear localization of MTHFD2 is required for correct mitosis progression, showing that the spatial regulation of metabolic enzymes contributes to chromosome-related functions. Similarly, Ctf18-dependent localization of interstitial telomeric sequences to nuclear pore complexes prevents chromosome fragility, linking nuclear pore components to chromosome stability. These examples illustrate that GO:0070202 includes processes that control both nuclear entry and subsequent chromosome targeting.
Chromatin Architecture and Cohesin Complexes
In simple terms: Large protein rings hold chromosomes together and help organize their 3D structure.
The cohesin complex, including STAG2, shapes spatial chromatin architecture and regulates gene expression. Mutations in STAG2 reshape cohesin-structured chromatin architecture in acute myeloid leukemia, altering the localization of proteins that depend on cohesin for chromosomal binding. This step highlights how higher-order chromosome organization feeds back into the regulation of protein localization.
Stepwise Establishment of Chromosome Architecture
In simple terms: During development, chromosome structures are built in a defined order.
The inactive X chromosome provides a paradigm for stepwise establishment of chromosome architecture. Du et al. showed that de novo establishment of inactive X chromosome architecture occurs in distinct stages, each requiring regulated protein localization. This developmental perspective underscores that GO:0070202 is not a single event but a temporally orchestrated program.
Key Genes Involved in GO:0070202 regulation of establishment of protein localization to chromosome
The following genes and proteins are experimentally implicated in the regulation of protein localization to chromosomes, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| METTL3 | m6A methyltransferase recruited to promoters | Maintains myeloid leukemia via m6A-dependent translation control |
| STAG2 | Cohesin complex subunit | Mutations reshape chromatin architecture in acute myeloid leukemia |
| MTHFD2 | Mitochondrial metabolic enzyme with nuclear localization | Nuclear localization required for mitosis progression |
| CTF18 | Replication factor C-like complex component | Mediates localization of telomeric sequences to nuclear pores |
| ACSS2 | Acetyl-CoA synthetase | Regulates histone acetylation and hippocampal memory |
| H3 | Histone H3 | Target of acetylation and methylation that recruits effector proteins |
| H4 | Histone H4 | Histone modification substrate influencing chromatin binding |
| BRD4 | Bromodomain-containing reader | Binds acetylated histones to regulate transcription |
| HP1 | Heterochromatin protein 1 | Binds H3K9me3 to establish heterochromatin |
| EZH2 | Polycomb repressive complex 2 subunit | Deposits H3K27me3 to recruit repressive proteins |
| CTCF | Chromatin architectural protein | Organizes topologically associating domains |
| SMC1A | Cohesin subunit | Maintains sister chromatid cohesion and chromatin loops |
| SMC3 | Cohesin subunit | Structural maintenance of chromosomes |
| RAD21 | Cohesin subunit | Cleavage and chromosome segregation |
| NUP98 | Nuclear pore complex protein | Fusion proteins target chromatin in leukemia |
| XRCC1 | DNA repair protein | Recruited to DNA damage sites on chromosomes |
| 53BP1 | DNA damage response protein | Localizes to double-strand breaks |
How Is regulation of establishment of protein localization to chromosome Regulated?
The regulation of protein localization to chromosomes is itself controlled by upstream signaling and metabolic cues. For example, acetyl-CoA synthetase (ACSS2) regulates histone acetylation in response to metabolic state, thereby influencing which proteins can bind chromatin. In leukemia, promoter-bound METTL3 maintains m6A-dependent translation control, showing that oncogenic signaling can hijack this regulatory layer. Additionally, cohesin complex mutations alter chromatin architecture, which in turn affects the localization of many chromatin-associated proteins. These examples indicate that GO:0070202 is responsive to both intracellular metabolism and oncogenic drivers.
regulation of establishment of protein localization to chromosome and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STAG2 | Acute myeloid leukemia | Knockout in AML cell lines; rescue with wild-type or mutant STAG2 |
| METTL3 | Myeloid leukemia | Knockout and overexpression in leukemia cells; m6A-seq |
| MTHFD2 | Mitotic defects | Knockout and nuclear-localization mutants in HeLa cells |
| CTF18 | Chromosome fragility | Knockout in human cells; telomere FISH |
| ACSS2 | Memory and neurological disorders | Knockout in mouse hippocampus; histone acetylation assays |
Acute Myeloid Leukemia
Mutations in the cohesin complex gene STAG2 reshape the spatial chromatin architecture and drive gene regulation in acute myeloid leukemia. This demonstrates that disruption of protein localization to chromosomes can directly contribute to leukemogenesis. Additionally, promoter-bound METTL3 maintains myeloid leukemia through m6A-dependent translation control, highlighting another mechanism by which chromatin-targeted proteins support cancer.
Developmental Disorders and X-Chromosome Inactivation
Stepwise de novo establishment of inactive X chromosome architecture is essential for normal female development. Defects in the regulated localization of proteins to the inactive X could lead to developmental abnormalities. This process serves as a model for understanding how chromosome architecture is built and maintained.
Mitotic Defects and Chromosome Instability
Nuclear localization of MTHFD2 is required for correct mitosis progression, and its loss leads to mitotic defects. Similarly, Ctf18-dependent localization of interstitial telomeric sequences to nuclear pore complexes prevents chromosome fragility. These findings link GO:0070202 to genome stability and cell division.
From regulation of establishment of protein localization to chromosome-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of STAG2 alter chromatin architecture? | CRISPR knockout of STAG2 in AML cell lines followed by Hi-C |
| Is METTL3 recruitment to promoters required for leukemia maintenance? | Knockout and promoter-tethering knock-in of METTL3 |
| Does nuclear MTHFD2 localization affect mitosis? | Point mutations disrupting nuclear localization signal; live imaging |
| How does Ctf18 mediate telomere localization to nuclear pores? | Knockout and tagged knock-in of CTF18; proximity labeling |
| What proteins bind specific histone marks? | ChromID proximity labeling with histone mark baits |
| Does ACSS2 regulate histone acetylation in memory? | Overexpression and knockout in mouse hippocampal neurons |
How to Study the regulation of establishment of protein localization to chromosome Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChromID | Protein interactome at specific chromatin marks | Identify readers of histone modifications |
| CRISPR knockout screens | Genes required for protein localization | Discover regulators of chromatin targeting |
| Hi-C | 3D chromatin architecture | Assess impact of STAG2 mutations |
| Live-cell imaging | Real-time protein localization | Track MTHFD2 during mitosis |
| ChIP-seq | Genome-wide binding sites | Map METTL3 or cohesin binding |
| m6A-seq | m6A RNA modification sites | Study METTL3-dependent translation |
| Proximity ligation assay | Protein-protein interactions in situ | Detect Ctf18 at nuclear pores |
| Histone acetylation assays | Levels of acetylated histones | Measure ACSS2 activity |
Proximity Labeling and Proteomics
ChromID is a powerful method to identify the protein interactome at specific chromatin marks. It uses a bait protein fused to a promiscuous biotin ligase to label nearby proteins, which are then identified by mass spectrometry. This approach can reveal which proteins are recruited to specific chromosomal locations under different conditions.
CRISPR Screens and Functional Genomics
Genome-wide CRISPR knockout screens can identify genes required for the localization of a reporter protein to chromosomes. For example, screens targeting chromatin modifiers have uncovered regulators of METTL3 recruitment. Such screens are complemented by bioinformatics analysis to prioritize hits.
Imaging and Live-Cell Tracking
Fluorescence microscopy of tagged proteins (e.g., GFP fusions) allows real-time tracking of protein localization to chromosomes. This is particularly useful for studying dynamic processes such as mitosis, where MTHFD2 localization can be monitored. Combined with FRAP or photoactivation, imaging provides kinetic parameters of protein targeting.
Chromosome Conformation Capture
Hi-C and related techniques measure 3D chromatin architecture, which is influenced by proteins such as STAG2 and cohesin. These methods can reveal how mutations in chromatin-targeting proteins alter chromosomal interactions and gene regulation.
How CRISPR Can Be Used to Study GO:0070202 regulation of establishment of protein localization to chromosome
Knockout
CRISPR knockout is used to delete genes such as STAG2, METTL3, or CTF18 to assess their requirement for protein localization to chromosomes. For example, STAG2 knockout in AML cells reshapes chromatin architecture, demonstrating a causal role. Knockout of METTL3 reduces m6A-dependent translation and impairs leukemia maintenance.
Point Mutation
Point mutations can be introduced to disrupt specific domains, such as the nuclear localization signal of MTHFD2, to test its role in mitosis. Similarly, catalytic-dead mutants of METTL3 can separate its enzymatic activity from its chromatin-binding function.
Knock-in
Knock-in of tagged versions of proteins (e.g., GFP or HA) allows visualization and immunoprecipitation of endogenous proteins. This is useful for tracking Ctf18 localization to nuclear pores or for ChromID experiments with histone mark baits.
Overexpression
Overexpression of wild-type or mutant proteins can test sufficiency for chromatin localization. For instance, overexpressing ACSS2 increases histone acetylation and enhances memory-related gene expression. Overexpression of METTL3 can enhance m6A deposition and translation control.
How EDITGENE Supports regulation of establishment of protein localization to chromosome Research
Researchers studying regulation of establishment of protein localization to chromosome-related genes often need to determine whether a candidate gene is causally involved in targeting proteins to chromatin. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of establishment of protein localization to chromosome research.
Frequently Asked Questions About regulation of establishment of protein localization to chromosome
What is GO:0070202?
GO:0070202 is the Gene Ontology term for regulation of establishment of protein localization to chromosome, defined as any process that modulates the frequency, rate or extent of the directed movement of a protein to a specific location on a chromosome.
What genes are involved in regulation of establishment of protein localization to chromosome?
Key genes include METTL3, STAG2, MTHFD2, CTF18, and ACSS2, which regulate chromatin targeting through m6A modification, cohesin architecture, nuclear localization, and histone acetylation.
How is protein localization to chromosomes regulated?
It is regulated by chromatin marks, histone modifications, nuclear transport, and higher-order chromosome architecture, often involving reader proteins that recognize specific histone tails.
What diseases are linked to defects in protein localization to chromosomes?
Defects are linked to acute myeloid leukemia, developmental disorders, and mitotic defects, with mutations in STAG2 and METTL3 being prominent examples.
What experimental models are used to study GO:0070202?
Common models include CRISPR knockout cell lines, knock-in of tagged proteins, overexpression systems, and proximity-labeling proteomics such as ChromID.
How can CRISPR screens identify regulators of protein localization to chromosomes?
Genome-wide CRISPR knockout or activation screens can be coupled with a reporter of protein localization to chromosomes, followed by sequencing to identify enriched sgRNAs.
What is the role of METTL3 in protein localization to chromosomes?
METTL3 is recruited to promoters where it deposits m6A on RNA, maintaining translation control and leukemia maintenance, illustrating how an RNA methyltransferase can be targeted to chromatin.
How does STAG2 mutation affect chromatin architecture?
STAG2 mutations reshape cohesin-structured spatial chromatin architecture, altering gene regulation and protein localization in acute myeloid leukemia.
Why is nuclear localization of MTHFD2 important?
Nuclear MTHFD2 is required for correct mitosis progression, and its loss leads to mitotic defects, linking metabolic enzymes to chromosome function.
What methods measure protein localization to chromosomes?
Methods include ChromID, ChIP-seq, live-cell imaging, Hi-C, and proximity ligation assays, each providing complementary information.
Conclusion
GO:0070202, regulation of establishment of protein localization to chromosome, is a critical biological process that ensures proteins reach their correct chromosomal destinations. It integrates chromatin marks, histone modifications, nuclear transport, and chromosome architecture to control gene expression and genome stability. Dysregulation of this process is implicated in leukemia, developmental disorders, and mitotic defects, making it a compelling area for both basic and translational research. By leveraging CRISPR-based models and advanced proteomic and imaging techniques, researchers can dissect the regulatory layers of GO:0070202. EDITGENE offers a full suite of services to support these efforts, from knockout and knock-in cell lines to library screening and bioinformatics, helping to accelerate discoveries in chromatin biology and disease.
References
- 1. Mews P et al.. 2017. Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory.. Nature 546(7658):381-386 PMID: 28562591
- 2. Barbieri I et al.. 2017. Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control.. Nature 552(7683):126-131 PMID: 29186125
- 4. Al Hajj M et al.. 2026. Ctf18-dependent localization of interstitial telomeric sequence to nuclear pore complexes prevents chromosome fragility.. Nucleic Acids Res 54(15) PMID: 42578369
- 5. Villaseñor R et al.. 2020. ChromID identifies the protein interactome at chromatin marks.. Nat Biotechnol 38(6):728-736 PMID: 32123383
- 6. Fischer A et al.. 2024. STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemia.. Cell Rep 43(8):114498 PMID: 39084219
- 7. Du Z et al.. 2024. Stepwise de novo establishment of inactive X chromosome architecture in early development.. Nat Genet 56(10):2185-2198 PMID: 39256583
- 8. Pardo-Lorente N et al.. 2024. Nuclear localization of MTHFD2 is required for correct mitosis progression.. Nat Commun 15(1):9529 PMID: 39532843
